Algocare
Practice tests Home All programs

Chlamydia

Introduction and Etiology of Chlamydial Infections

Chlamydia is one of the most prevalent bacterial sexually transmitted infections globally and a major public health concern across Nigeria. The causative agent is Chlamydia trachomatis, an obligate intracellular bacterium. This means the organism cannot reproduce outside of a host cell, relying entirely on human epithelial cells to replicate. Its unique developmental cycle alternates between an infectious, metabolically inactive form called the elementary body, and a non-infectious, metabolically active reproductive form called the reticulate body.

Transmission Dynamics and Risk Factors

Transmission occurs primarily through unprotected vaginal, anal, or oral sexual contact with an infected partner. Additionally, vertical transmission can happen during vaginal delivery when a neonate passes through an infected birth canal. In many Nigerian communities, key risk factors include young age, having multiple concurrent sexual partners, inconsistent barrier contraceptive use, and a history of previous sexually transmitted infections. Many individuals remain asymptomatic, unknowingly maintaining transmission cycles within the community.

Clinical Presentation in Male and Female Patients

Chlamydia is widely known as a "silent infection" because up to seventy percent of women and a significant percentage of men show no outward signs initially.

Left unrecognized, the infection ascends from the lower reproductive tract to cause upper tract complications.

Screening and Diagnostic Approaches in Midwifery Practice

Accurate diagnosis is vital for effective clinical management. In midwifery practice, screening is routinely offered during antenatal booking visits, particularly for high-risk populations.

Pharmacological Management and Partner Notification

Treatment of uncomplicated chlamydia relies on specific oral antibiotic therapy. Standard regimens typically include Azithromycin as a single oral dose or Doxycycline taken twice daily for seven days. Doxycycline is contraindicated during pregnancy, making Azithromycin or Ampicillin preferred choices for expectant mothers.

Effective management requires simultaneous treatment of all sexual partners within the preceding sixty days to prevent reinfection. Midwives must counsel patients on abstinence until treatment is fully completed and symptoms resolve.

Complications in Pregnancy and Neonates

Untreated chlamydial infections during pregnancy pose severe risks to both mother and baby. Ascending infection can lead to miscarriage, premature rupture of membranes, preterm labor, and postpartum endometritis.

For the newborn exposed during birth, complications manifest primarily as neonatal conjunctivitis (ophthalmia neonatorum), appearing within one to two weeks after birth, and chlamydial pneumonia, characterized by a distinctive staccato cough and tachypnea.

Prevention Strategies and Public Health Impact

Public health strategies focus on breaking transmission chains through community education, promotion of barrier methods such as male and female condoms, routine antenatal screening, and prompt partner notification. Midwives play a frontline educational role in dispelling cultural stigmas that discourage individuals from seeking timely care. Reducing the burden of chlamydia directly protects female reproductive health and decreases rates of preventable tubal infertility across Nigerian communities.

Test yourself on this topic →
Privacy Policy Terms & Disclaimer